Drawing for ENDOVE

USPTO serial 85485561

ENDOVE

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
—
Law office
NEW APPLICATION PROCESSING

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ENDOVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maribeth Day Case

MARIBETH DAY CASE GLAXOSMITHKLINE5 MOORE DRRESEARCH TRIANGLE PARK, NC 27709-0183UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; VaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 26, 2012MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Jan 26, 2012ABN1ABANDONMENT - EXPRESS MAILED—
Jan 25, 2012EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Dec 7, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 6, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance